Trials / Completed
CompletedNCT01170091
Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 651 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Safety and Effect of Mirapex(Pramipexole) tablet among Korean Restless Legs Syndrome Patients: An Open-Label, Postmarketing Surveillance Study
Detailed description
Study Design:
Conditions
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2011-02-01
- First posted
- 2010-07-27
- Last updated
- 2014-04-11
- Results posted
- 2012-09-11
Locations
36 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01170091. Inclusion in this directory is not an endorsement.